COVID-19 Collection

Journal article

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study

Abstract:: Background The memory immune response is crucial for preventing reinfection or reducing disease severity. However, the robustness and functionality of the humoral and T-cell response to SARS-CoV-2 remains unknown 12 months after initial infection. The aim of this study is to investigate the durability and functionality of the humoral and T-cell response to the original SARS-CoV-2 strain and variants in recovered patients 12 months after infection.
Methods Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Guo, L., Wang, G., Wang, Y., Zhang, Q., Ren, L., Gu, X., Huang, T., Zhong, J., Wang, Y., Wang, X., Huang, L., Xu, L., Wang, C., Chen, L., Xiao, X., Peng, Y., Knight, J. C., Dong, T., Cao, B., & Wang, J. (2022). SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. Lancet Microbe, 3(5), E348–E356.

MLA Style

Guo, L, et al. “SARS-CoV-2-Specific Antibody and T-Cell Responses 1 Year after Infection in People Recovered from COVID-19: a Longitudinal Cohort Study.” Lancet Microbe, vol. 3, no. 5, 2022, pp. E348–E356.

Chicago Style

Guo, L, G Wang, Y Wang, et al. 2022. “SARS-CoV-2-Specific Antibody and T-Cell Responses 1 Year after Infection in People Recovered from COVID-19: a Longitudinal Cohort Study.” Lancet Microbe 3 (5): E348–E356.
Print

Access Document

Files:: Guo_et_al_2022_SARSCoV2_specific_antibodyV.pdf

(Preview, Version of record, pdf, 769.7KB, Terms of use)

Publisher copy:: 10.1016/S2666-5247(22)00036-2

Authors

+ Guo, L More by this author

Role:: Author

+ Wang, G More by this author

Role:: Author

+ Wang, Y More by this author

Role:: Author

+ Zhang, Q More by this author

Role:: Author

+ Ren, L More by this author

Role:: Author

More authors...

+ Medical Research Council More from this funder

Grant:: MR/L018942/1; MR/P021336/1 Crick code 10590

+ Royal Society More from this funder

Grant:: NI140175

+ Wellcome Trust More from this funder

Grant:: 097813/Z/11/A

+ John Fell Fund More from this funder

Publisher:: Elsevier
Journal:: Lancet Microbe More from this journal
Volume:: 3
Issue:: 5
Pages:: E348-E356
Publication date:: 2022-03-23
DOI:: 10.1016/S2666-5247(22)00036-2
EISSN:: 2666-5247

Language:: English
Keywords:: FFR
Pubs id:: 1248979
Local pid:: pubs:1248979
Deposit date:: 2022-03-31
ARK identifier:: ark:/29072/ora_b6f26422216843e7840ea508667b972d

Terms of use

Copyright holder:: Guo et al.
Copyright date:: 2022
Rights statement:: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.

Licence:: CC Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP